Sign In  |  Register  |  About Los Altos  |  Contact Us

Los Altos, CA
September 01, 2020 1:26pm
7-Day Forecast | Traffic

  • Search Hotels in Los Altos

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Salarius Pharmaceuticals Inc (NQ: SLRX )

1.480 -0.130 (-8.07%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Salarius Pharmaceuticals Inc

< Previous 1 2 3 4 5 6 Next >
The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs
Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results.... 
Via Benzinga
Exposures Product Safety
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Odonate Therapeutics (NASDAQ:ODT)... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Alterity Therapeutics (NASDAQ:ATHE 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers AnPac Bio-Medical Science (NASDAQ:ANPC) stock rose 21.47% to $5.26 during Friday's pre-market session. The company's market cap stands at $68.5 million.... 
Via Benzinga
Salarius Pharmaceuticals Launches Mid-Stage Blood Cancer Trial With Seclidemstat
Salarius Pharmaceuticals Inc (NASDAQ: SLRX) has initiated an investigator-initiated Phase 1/2 trial to investigate seclidemstat as a potential treatment for... 
Via Benzinga
Salarius' Seclidemstat Shows Single-Agent Drug Activity in Heavily Pre-Treated Sarcomas Patients
Salarius Pharmaceuticals Inc (NASDAQ: SLRX) presented data at the American Society of Clinical Oncology Virtual Annual Meeting for seclidemstat, a reversible... 
Via Benzinga
64 Biggest Movers From Friday
Gainers Senseonics Holdings, Inc. (NYSE: SENS) jumped 42% to settle at $2.91 on Friday after the company disclosed results from a PROMISE study evaluating its Eversense CGM... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Windtree Therapeutics (NASDAQ:WINT) shares rose 35.85% to $2.69 during Friday's regular session. Trading volume for this security as of 12:30 EST is 117.5... 
Via Benzinga
40 Stocks Moving In Friday's Mid-Day Session
Gainers SemiLEDs Corporation (NASDAQ: LEDS) shares jumped 68.8% to $25.49 after gaining 23% on Thursday. Senseonics Holdings, Inc. (NYSE: SENS) gained 26% to $2.5817 after the... 
Via Benzinga
24 Stocks Moving in Friday's Pre-Market Session
Gainers Senseonics Holdings, Inc. (NYSE: SENS) rose 37.1% to $2.81 in pre-market trading after the company disclosed results from a PROMISE study evaluating its Eversense CGM... 
Via Benzinga
55 Biggest Movers From Yesterday
Gainers DLocal Limited (NASDAQ: DLO) shares jumped 54.2% to close at $32.39 on Thursday. DLocal raised around $92.6 million from the sale of 4.4 million shares in its IPO. GTT... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
46 Stocks Moving In Thursday's Mid-Day Session
Gainers GTT Communications, Inc. (NYSE: GTT) shares jumped 66% to $4.16 on abnormally-high volume. The company’s stock also jumped over 57% on Wednesday. Ra Medical Systems... 
Via Benzinga
28 Stocks Moving in Thursday's Pre-Market Session
Gainers GTT Communications, Inc. (NYSE: GTT) rose 41.6% to $3.54 in pre-market trading after jumping over 57% on Wednesday. Workhorse Group Inc. (NASDAQ: WKHS) rose 29.2% to $14... 
Via Benzinga
The Week Ahead In Biotech: ASCO Presentations Front And Center, FDA Decisions Due For Scynexis, Liminal And Alkermes
After having declined through the first half of the week, biotech stocks staged a recovery to close higher in the trading week ended May 28. Broader market sentiment and company-... 
Via Benzinga
Exposures Product Safety
Looking Into Salarius Pharmaceuticals's Return On Capital Employed
In Q1, Salarius Pharmaceuticals (NASDAQ:SLRX) posted sales of $1.27 million. Earnings were up 2.69%, but Salarius Pharmaceuticals still reported an overall loss of $1.80 million.... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Strongbridge Biopharma (NASDAQ:SBBP) stock moved upwards by 14.1% to $2.75 during Monday's pre-market session. The market value of their outstanding shares is... 
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Sio Gene Therapies (NASDAQ:SIOX) ... 
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Evaxion Biotech (NASDAQ:EVAX) sha... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Celyad Oncology (NASDAQ:CYAD) sto... 
Via Benzinga
Salarius Pharmaceuticals: Q1 Earnings Insights
Shares of Salarius Pharmaceuticals (NASDAQ:SLRX) rose in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share rose 72.73% year over... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers NovoCure (NASDAQ:NVCR) shares rose 63.02% to $215.0 during Tuesday's pre-market session. The company's market cap stands at $22.0 billion. Axcella Health (... 
Via Benzinga
The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) HOOKIPA Pharma Inc. (NASDAQ... 
Via Benzinga
Exposures COVID-19
Earnings Scheduled For May 12, 2021
Companies Reporting Before The Bell • PolyPid (NASDAQ:PYPD) is estimated to report earnings for its first quarter. • Boyd Gaming (NYSE:BYD) is projected to report... 
Via Benzinga
The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings
Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came... 
Via Benzinga
Exposures COVID-19 Product Safety
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 LosAltos.com & California Media Partners, LLC. All rights reserved.